Altocor SAVE program
McKesson will administer Andrx' Select Altocor for Value & Effectiveness discount card plan for extended-release lovastatin. Under the program slated for June launch, Altocor users will pay approximately $18 less per month for the drug; a year's supply will cost up to $1,000 less than other branded statins. SAVE has no age or income restrictions and will encompass cash payers as well as patients with insurance. Andrx previously said the program would target cash-paying seniors ("The Pink Sheet" March 31, p. 25)...
You may also be interested in...
In its “robust, holistic hub” online, firms in the VMS product supply chain can determine their needs, “by product, solution or delivery formats,” and use a “comprehensive and unique portfolio” to “turn natural sources into shelf-ready products.”
Plus deals involving Astellas/Actinium, Sosei/PharmEnable, Aadi/EOC Pharma, BeiGene/Strand, Chi-Med/Inmagene, Alteogen/Intas, Sosei/AbbVie, Y-Biologics/3D Medicines.
If J&J’s gamble on a single dose pays off, it could rapidly advance the fight against SARS-CoV2 – but a second study will provide a safety net.